GEN Exclusives

More »

GEN News Highlights

More »
Aug 5, 2013

Which Life Science Leaders Under 40 Are Shaking Up the Industry the Most?

  • If you combine the old clichés that the “future belongs to the young” and “the future is now” you could really be talking about today’s life science industry. For one of the most striking recent developments in the evolution of the biotech business is the number of under-40 individuals who are now at the helm of biopharmaceutical companies. Gone are the days when it was virtually axiomatic that a man or a woman (mostly men actually) who had spent many years working at major pharmaceutical companies would be hired for any open spot as president or CEO at a biotech company.

    Now, having grown up in a completely interconnected world and weaned on the internet and other modern wonders of technology, increasing numbers of young people have the smarts, the drive, and the background to accept the challenge of running a biotech company and making profitability the goal. Taking their cues from Bill Gates and Steve Jobs, their motto seems to be that vision can trump experience.

    GEN is putting together a list of the “Top Life Science Leaders Under 40” and we want your input. Please send your candidate to for our listing and provide us with the name, age, position, company affiliation, and reason why you believe your nomination should be on our list. If your suggested candidate makes the list, you could win a $10 coffee gift card. We welcome your participation!

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

New NIH Budget Proposal Leaves Many Confused and Unsettled

Do you think that using the so-called “mandatory budget funds” to pay for the proposed $825 million increase, as well as $1 billion of the NIH’s existing budget is a good idea?

More »